NIDDM is characterized by insulin resistance, in which the primary insulin-target organs, such as skeletal muscle, liver, and adipocytes are poorly responsive to insulin action, which may combine with reduced insulin secretion caused by a progressive loss of β-cell function [5]. The gene discussed is INS; the disease is Insulin resistance.